Project Details
Description
A Phase 3 Trial of ADXS11-001 (NSC #752718) Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/16 → 3/31/24 |
Funding
- ADVAXIS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.